We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The retrospective analysis included 26 clinical studies ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has recently updated its clinical study ...

Patients with severe asthma receiving mepolizumab experience reductions in healthcare resource use and improvements in work ...

Severe asthma treatment with the interleukin-5 antagonist mepolizumab (Nucala) reduced the need to take oral corticosteroids in patients who had depended on steroids to control symptoms, according to ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN ANTONIO -- ...

Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with a 55% reduction in COPD exacerbations post initiation. A ...

While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma? Mepolizumab use significantly reduced the use of oral ...

Mepolizumab was found to reduce nasal polyp size and nasal obstruction in patients with chronic rhinosinusitis with nasal polyps regardless of the presence of potentially exacerbating comorbidities.

Adding mepolizumab to inhaled triple therapy significantly improved exacerbation outcomes compared with placebo in adults with chronic obstructive pulmonary disease (COPD), based on data from the ...

nasal polyps illustration The phase 3 SYNAPSE clinical trial evaluated the efficacy of mepolizumab in improving sense of smell in patients with chronic rhinosinusitis with nasal polyps. The monoclonal ...

Please provide your email address to receive an email when new articles are posted on . Mepolizumab reduced polyp size and nasal obstructions in patients with chronic rhinosinusitis with nasal polyps ...

In a real-world setting, mepolizumab therapy significantly reduced the rate of asthma exacerbations and their related costs. HOUSTON — In a real-world setting, mepolizumab therapy significantly ...